Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma

NCT01272102 is registered in ClinicalTrials.gov with Carl Zeiss Meditec, Inc. as lead sponsor.

NCT NCT01272102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01272102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Lead sponsor
Carl Zeiss Meditec, Inc.
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2011
Enrollment
119 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma